Insight Molecular Diagnostics’s (IMDX) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting Insight Molecular Diagnostics is a Buy.
Insight Molecular Diagnostics’s (IMDX) 20-Day exponential moving average is $2.95, while Insight Molecular Diagnostics’s (IMDX) share price is $2.49, making it a Sell.
Insight Molecular Diagnostics’s (IMDX) 50-Day exponential moving average is $3.40, while Insight Molecular Diagnostics’s (IMDX) share price is $2.49, making it a Sell.
Insight Molecular Diagnostics’s (IMDX) 10-Day exponential moving average is $2.77, while Insight Molecular Diagnostics’s (IMDX) share price is $2.49, making it a Sell.
Insight Molecular Diagnostics’s (IMDX) 100-Day exponential moving average is $3.93, while Insight Molecular Diagnostics’s (IMDX) share price is $2.49, making it a Sell.
Insight Molecular Diagnostics’s (IMDX) stock price is $2.49 and Insight Molecular Diagnostics’s (IMDX) 50-day simple moving average is $3.45, creating a Sell signal.
Insight Molecular Diagnostics’s (IMDX) stock price is $2.49 and Insight Molecular Diagnostics’s (IMDX) 100-day simple moving average is $4.15, creating a Sell signal.
Insight Molecular Diagnostics’s (IMDX) stock price is $2.49 and Insight Molecular Diagnostics’s (IMDX) 200-day simple moving average is $4.64, creating a Sell signal.